期刊文献+

内镜下低温等离子射频消融术治疗早期声门型喉癌患者的效果分析 被引量:3

Efficacy Analysis of Endoscopic Low-temperature Plasma Radiofrequency Ablation in the Treatment of Early Glottic Laryngeal Cancer
在线阅读 下载PDF
导出
摘要 目的:探讨内镜下低温等离子射频消融术治疗早期声门型喉癌患者效果。方法:回顾性分析2020年1-12月佳木斯市东风区人民医院收治的100例早期声门型喉癌患者的临床资料,依据手术治疗方案的差异将患者分成对照组和研究组,每组50例。对照组采用喉裂开手术治疗,研究组采用内镜下低温等离子射频消融术治疗。比较两组视觉模拟评分法(VAS)评分、术后住院时间、术中出血量、手术时间、术后并发症发生情况、嗓音声学检测[谐噪比(HNR)、振幅微扰(Shimmer)、基频微扰(Jitter)]及生活质量评分。结果:研究组术后3 d的VAS评分低于对照组,术中出血量少于对照组,术后住院时间和手术时间均短于对照组,差异均有统计学意义(P<0.05)。研究组并发症发生率低于对照组(P<0.05)。术后7、30 d,研究组HNR均高于对照组,研究组Shimmer、Jitter均低于对照组,差异均有统计学意义(P<0.05)。术后30 d、术后半年、术后1年,研究组生活质量评分均高于对照组(P<0.05)。结论:内镜下低温等离子射频消融术治疗早期声门型喉癌有较高的安全性,患者嗓音功能能够更快、更好恢复,患者术后疼痛程度能够得到有效减少,生活质量得到显著改善,临床治疗效果确切,值得应用。 Objective:To investigate the effect of endoscopic low-temperature plasma radiofrequency ablation in the treatment of early glottic laryngeal cancer.Method:The clinical data of 100 patients with early glottic laryngeal cancer admitted to Jiamusi Dongfeng District People’s Hospital from January to December 2020 were retrospectively analyzed,the patients were divided into control group and study group according to the difference of surgical treatment plan,with 50 cases in each group.The control group was treated with laryngeal dehiscence operation,and the study group was treated with endoscopic low-temperature plasma radiofrequency ablation.The visual analogue scale(VAS)scores,postoperative hospital stay,intraoperative blood loss,operation time,postoperative complications,voice acoustic detection[harmonic noise ratio(HNR),amplitude perturbation(Shimmer),fundamental frequency perturbation(Jitter)]and quality of life scores were compared between the two groups.Result:The VAS score of the study group was lower than that of the control group 3 d after operation,the intraoperative blood loss of the study group was less than that of the control group,the postoperative hospital stay and operation time of the study group were shorter than those of the control group,the differences were statistically significant(P<0.05).The complication rate of the study group was lower than that of the control group(P<0.05).At 7 and 30 d after operation,HNR of the study group were higher than those of the control group,Shimmer and Jitter of the study group were lower than those of the control group,the differences were statistically significant(P<0.05).The scores of quality of life of the study group were higher than those of the control group at 30 d,6 months and 1 year after operation(P<0.05).Conclusion:Endoscopic low-temperature plasma radiofrequency ablation for patients with early glottic laryngeal cancer has high safety,the voice function of patients can recover faster and better,the degree of postoperative pain can be effectively reduced,the quality of life can be significantly improved,and the clinical treatment effect is accurate,which is worthy of application.
作者 苏钰茗 牟基伟 SU Yuming;MOU Jiwei(Jiamusi Dongfeng District People’s Hospital,Heilongjiang Province,Jiamusi 154005,China;不详)
出处 《中国医学创新》 CAS 2022年第28期68-73,共6页 Medical Innovation of China
关键词 内镜下低温等离子射频消融术 早期声门型喉癌 语音功能 Endoscopic low-temperature plasma radiofrequency ablation Early glottic laryngeal cancer Voice function
作者简介 通信作者:苏钰茗。
  • 相关文献

参考文献19

二级参考文献141

  • 1万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1442
  • 2万崇华,李晓梅,赵旭东,杨玉萍,潘家华,周曾芬,杨铮,张晓磬,杨瑞雪,高丽.慢性病患者生命质量测定量表体系研究[J].中国行为医学科学,2005,14(12):1130-1131. 被引量:88
  • 3徐文.内镜下声带切除术分类标准指南(欧洲喉科学会工作委员会推荐)[J].国际耳鼻咽喉头颈外科杂志,2006,30(5):331-333. 被引量:6
  • 4Holzner B,Kemmler G,Sperner Unterueger B, et al. Quality of life measurement in oncology-a matter of the assessment instrument? [J].Eur J Cancer, 2001,37(18):2349-2356.
  • 5Skevington S M,Sartorius N,Amir M, et al. Developing methods for assessing quality of life in different cultural settings[J]. Soc Psychiatry Psychiatr Epidemiol, 2004,39 (1) : 1-8
  • 6Sprangers M A, Cull A, Groenvold M, et al. The European organization for research and treatment of cancer approach to developing questionnaire modules; an update and overview[J]. Qual Life Res,1998,7(4) :291-300.
  • 7Aaronson N K,Ahrnendzai S,Bergman B, et al. The EORTC QLQ- C30:a quality of life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst, 1993,85(5): 365-376.
  • 8Bergman B, Aaronson N K, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30)for use in lung cancer clinical trials [J]. Eur J Cancer 1994,30(5) :635-642.
  • 9Fitzsimmons D, Johnson C D, George S, et al. Development of disease specific quality of Iife(QoL) questionnaire module to supplement the EORTC core cancer QOL questionnaire, the QLQ-C30 in patients with pancreatic cancer[J]. Eur J Cancer, 1999,35 (6):939-941.
  • 10Easson A M, Bezjak A, Ross S, et al. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites[J]. Ann Surg Oncol,2007,14(8) :2348-2357.

共引文献262

同被引文献27

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部